Tag: weight_loss
-
Media Monitor: Washington Post's new advice column addresses marital secrecy over weight-loss medication
The Washington Post's new "Say More" column features a reader's dilemma about concealing weight-loss pill use and costs from their spouse.
HealthMediaBusinessMedical ScienceSocial IssuesDigital and Print Publishing Washington PostSay MoreRelationship adviceWegovyWeight lossMarriagePersonal financeThe Washington Post
-
Media Monitor: Medicare to cover GLP-1 weight loss drugs
The Washington Post reports Medicare will begin covering GLP-1 drugs for weight loss, with patients paying a $50 co-payment under a Trump administration pilot program.
HealthPolitics and GovernmentBusinessFederal GovernmentGeneral PoliticsEconomyMedical Science MedicareGLP-1 drugsweight losshealth insuranceTrump administrationpilot programWashington PostThe Washington Post
-
Media Monitor: NPR reports on gut health, GLP-1 drug insurance, and explosive power training
NPR Health is reporting on the latest in gut microbiome research, challenges with health insurance coverage for GLP-1 weight loss drugs, and the benefits of explosive power training for agility and injury prevention.
HealthBusinessScience & TechnologyMediaMedical ScienceEconomySocial IssuesDigital and Print PublishingMusicLegal Gut microbiomeGLP-1 drugsHealth insuranceExplosive power trainingWeight lossExerciseDietNPR Health
-
Media Monitor: NPR Health Reports on Gut Microbiome, GLP-1 Drug Coverage, and Explosive Power Training
NPR Health reports on the complexities of gut microbiome health, challenges with GLP-1 drug insurance coverage, and the benefits of explosive power training for agility and injury prevention.
HealthScience & TechnologyPolitics and GovernmentSportMedical ScienceSocial IssuesLegalEducationEconomy Gut microbiomeHealth insuranceGLP-1 drugsWeight lossExplosive power trainingNutritionExerciseNPR Health
-
Media Monitor: ABC News reports on US-Iran tensions, global economy, and domestic issues
ABC News is reporting on U.S. strikes against Iran, the resilience of the global economy, dangerous weight loss peptides, and changes to Australian defense home loans.
Politics and GovernmentBusinessWorldHealthGeneral PoliticsEconomyMedical ScienceMilitaryAustralasia IranGlobal EconomyWeight LossAustraliaEarthquakesFootballABC News AM
-
FDA Approves New Kidney Risk Warnings for OTC Weight Loss Drug alli
The FDA has approved new labeling for the OTC weight loss drug alli (orlistat) 60 mg, warning of rare risks including acute kidney injury and kidney stones. Consumers with a history of kidney issues should consult a doctor before use.
HealthPolitics and GovernmentMedical ScienceFederal GovernmentEducation FDAalliorlistatkidney injurykidney stonesweight lossDrug SafetyFood RecallsDrugs
-
Media Monitor: The Washington Post Reports on Next-Gen Weight-Loss Drugs, Primary Results, and Scientific Discoveries
The Washington Post is reporting on advancements in weight-loss drugs, key takeaways from recent primaries in Maine and South Carolina, and scientific insights into aging and birth order.
MediaHealthPolitics and GovernmentScience & TechnologyDigital and Print PublishingMedical ScienceGeneral PoliticsElectionSocial Issues GLP-1 drugsWeight lossMaineSouth CarolinaPrimary electionsEmma MazzengaBirth orderThe Washington Post
-
Media Monitor: Washington Post Reports on New Weight Loss Drug, Congressional Absence, and Fair Performer Withdrawals
The Washington Post is reporting on Eli Lilly's experimental GLP-1 drug, Rep. Tom Kean Jr.'s absence from Congress, and performer withdrawals from the Great American State Fair.
HealthPolitics and GovernmentEntertainmentBusinessMedical ScienceGeneral PoliticsCongressSocial IssuesMusic Eli LillyGLP-1Tom Kean Jr.Great American State FairPoliticsWeight LossThe Washington Post
-
NIH Researchers Identify Pathway to Enhance GLP-1 Weight Loss Effects
NIH scientists have identified key intracellular signaling pathways in neurons that influence GLP-1 drug semaglutide's weight-loss effects. Modulating these pathways, particularly cAMP levels, could lead to more sustained and effective treatments for obesity.
HealthScience & TechnologyPolitics and GovernmentMedical ScienceFederal Government NIHGLP-1SemaglutideWeight LosscAMPNIDDKRoflumilastNational Institutes of Health
-
Media Monitor: Eli Lilly's New Weight-Loss Drug Shows Dramatic Results
TIME is reporting that Eli Lilly's experimental weight-loss drug achieved significant body weight reduction in trials, comparable to bariatric surgery, without increased side effects.
HealthBusinessScience & TechnologyMedical Science Eli Lillyweight lossobesitypharmaceuticalsdrug developmenthormonesTIME Health
-
Media Monitor: PolitiFact Debunks Trump's Claim on Substantially Lower Gas Prices
PolitiFact reports President Donald Trump's claim that gas prices had "come down very substantially" is inaccurate, citing AAA data showing daily increases before a minimal drop. It also covered GLP-1 medications for weight loss.
Politics and GovernmentBusinessHealthWorldEconomyElectionGeneral PoliticsMedical ScienceMiddle EastEurope Donald TrumpGas PricesPolitiFactAmerican Automobile AssociationStrait of HormuzGLP-1sWeight LossPolitiFact's Ellen Hine